2017
DOI: 10.1016/j.juro.2017.02.3085
|View full text |Cite
|
Sign up to set email alerts
|

Mp98-20 the Role of Toll-Like Receptor 4 in Bladder Cancer Progression.

Abstract: cancer cells. Also our findings suggest that through the inhibition of HSP90 activity, antitumor effect of PI3K/mTOR inhibitor and platinum combination therapy can be synergistically potentiated.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles